Compare Elder Pharma with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs AJANTA PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA AJANTA PHARMA ELDER PHARMA/
AJANTA PHARMA
 
P/E (TTM) x -0.2 28.2 - View Chart
P/BV x 0.1 7.8 1.3% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 ELDER PHARMA   AJANTA PHARMA
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
AJANTA PHARMA
Mar-19
ELDER PHARMA/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs3801,422 26.7%   
Low Rs188898 20.9%   
Sales per share (Unadj.) Rs491.2233.5 210.3%  
Earnings per share (Unadj.) Rs-3.244.0 -7.2%  
Cash flow per share (Unadj.) Rs14.452.2 27.6%  
Dividends per share (Unadj.) Rs09.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs376.5255.1 147.6%  
Shares outstanding (eoy) m20.5488.02 23.3%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x0.65.0 11.6%   
Avg P/E ratio x-89.326.4 -338.4%  
P/CF ratio (eoy) x19.722.2 88.6%  
Price / Book Value ratio x0.84.5 16.6%  
Dividend payout %020.5 0.0%   
Avg Mkt Cap Rs m5,833102,081 5.7%   
No. of employees `000NA6.8 0.0%   
Total wages/salary Rs m2,1794,307 50.6%   
Avg. sales/employee Rs ThNM3,022.6-  
Avg. wages/employee Rs ThNM633.4-  
Avg. net profit/employee Rs ThNM569.1-  
INCOME DATA
Net Sales Rs m10,08920,554 49.1%  
Other income Rs m257211 121.7%   
Total revenues Rs m10,34620,765 49.8%   
Gross profit Rs m-7925,664 -14.0%  
Depreciation Rs m361721 50.1%   
Interest Rs m2,75612 23,761.2%   
Profit before tax Rs m-3,6535,143 -71.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m1251,273 9.8%   
Profit after tax Rs m-653,870 -1.7%  
Gross profit margin %-7.827.6 -28.5%  
Effective tax rate %-3.424.8 -13.8%   
Net profit margin %-0.618.8 -3.4%  
BALANCE SHEET DATA
Current assets Rs m9,24011,812 78.2%   
Current liabilities Rs m9,9983,776 264.7%   
Net working cap to sales %-7.539.1 -19.2%  
Current ratio x0.93.1 29.5%  
Inventory Days Days4677 59.8%  
Debtors Days Days6082 73.5%  
Net fixed assets Rs m10,12414,398 70.3%   
Share capital Rs m206175 117.3%   
"Free" reserves Rs m5,58222,277 25.1%   
Net worth Rs m7,73422,452 34.4%   
Long term debt Rs m4,8897 74,075.8%   
Total assets Rs m22,88226,962 84.9%  
Interest coverage x-0.3444.3 -0.1%   
Debt to equity ratio x0.60 215,058.7%  
Sales to assets ratio x0.40.8 57.8%   
Return on assets %11.814.4 81.7%  
Return on equity %-0.817.2 -4.9%  
Return on capital %22.323.0 97.2%  
Exports to sales %3.00-   
Imports to sales %0.40-   
Exports (fob) Rs m307NA-   
Imports (cif) Rs m43NA-   
Fx inflow Rs m30710,682 2.9%   
Fx outflow Rs m1252,102 6.0%   
Net fx Rs m1818,580 2.1%   
CASH FLOW
From Operations Rs m11,7543,748 313.6%  
From Investments Rs m-561-2,228 25.2%  
From Financial Activity Rs m-6,762-1,475 458.6%  
Net Cashflow Rs m4,43245 9,804.6%  

Share Holding

Indian Promoters % 39.6 73.8 53.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 1.6 483.9%  
FIIs % 16.8 7.6 221.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 17.0 212.4%  
Shareholders   16,479 20,968 78.6%  
Pledged promoter(s) holding % 77.6 4.4 1,766.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   DR. REDDYS LAB  IPCA LABS  JUBILANT PHARMOVA   SUN PHARMA  PIRAMAL ENTERPRISES  

Compare ELDER PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 272 Points Higher; Hindalco, Hero MotoCorp & Wipro Surge Over 4%(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views on News

WOCKHARDT at 52 Week High; BSE 500 Index Up 1.0% (Market Updates)

May 6, 2021 | Updated on May 6, 2021

WOCKHARDT share price has hit a 52-week high. It is presently trading at Rs 598. BSE 500 Index is up by 0.6% at 19,889. Within the BSE 500, WOCKHARDT (up 10.0%) and COFORGE (up 17.5%) are among the top gainers, while top losers are FUTURE LIFESTYLE and E.I.D. PARRY.

AJANTA PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 64.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 64.2% YoY). Sales on the other hand came in at Rs 7 bn (up 15.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 28.9% (Quarterly Result Update)

Aug 24, 2020 | Updated on Aug 24, 2020

For the quarter ended June 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 7 bn (up 9.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 45.3% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 45.3% YoY). Sales on the other hand came in at Rs 7 bn (up 32.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

More Views on News

Most Popular

Power Grid's InvIT IPO: Key Points to Consider(Company Info)

Apr 23, 2021

In this article, we discuss the key reasons why the stock of Power Grid was in focus today.

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

This Fund Manager Has Taken the World by Storm. Will You Invest With Her?(Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 5-YR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS